Over Priced Drug
- All
- News
-
New "Vaccine-Like" HIV Drug Could Cost 1,000 Times Less Than Current Price
A new "vaccine-like" HIV drug that currently costs over $40,000 per person a year could be made for as little as $40, researchers estimated on Tuesday.
-
Sweden Forced to Pay Jailed Drug Dealer Over $1.5 Million in Bitcoin: Find Out Why
In a recent ruling, Sweden's government is being forced to pay more than $1.5 Million (roughly Rs. 11 crores) to a drug dealer who was jailed in 2019 after the Bitcoin he had illegally amassed appreciated while he was in custody. Read all about it here.
-
Cadila Healthcare Gains Over 2% After Unit Buys Drug For Menkes Disease
Cadila Healthcare said that its US subsidiary has acquired an experimental drug from Cyprium for treating Menkes disease, which is a rare recessive pediatric disease
-
Gilead Prices COVID-19 Drug Remdesivir At $2,340 Per Patient In Developed Nations
Gilead Sciences Inc on Monday priced its COVID-19 antiviral remdesivir at $2,340 per patient for wealthier nations and agreed to send nearly all of its supply of the drug to the United States over the next three months.
-
Cipla Gets Regulatory Nod To Make Gilead's COVID-19 Drug, Shares Hit Record High
Cipla shares surged over 9% after it got an approval from DCGI to manufacture and market generic COVID-19 drug Remdesivir.
-
Why Shares Of This Bengaluru-Based Drug Maker Plunged Over 8% Today
US FDA had inspected Strides Pharma's drug manufacturing facility in Puducherry from January 28 to February 5, 2019 and said that the company was caught trying to dispose quality-control records.
-
Expected Rise In Drug Prices Post-GST Create Panic
The expected rise in drug prices post-GST has created chaos among the customers who are in dire need of life-surviving drugs. With uncertainty over tax slabs, pharma companies are in complete disorder.
-
US Consumers Will Want Donald Trump, Congress To Take On Drug Prices
Americans' growing alarm over rising prescription drug costs will pressure a new US administration and Congress to take action on pharmaceutical pricing, industry executives and healthcare experts say.
-
Hillary Clinton Win May Pose Pricing Challenges For Pharma Firms: Report
Both US presidential candidates have argued in favour of allowing the US government's Medicare programme, which accounts for over 20 per cent of total US drug spend, to directly negotiate drug prices with manufacturers.
-
Government Cuts Prices Of 10 Drugs, Brings 8 More Under Control
Government has slashed prices of 10 more drugs while bringing eight new medicines, including paracetamol, under price control for the first time in its bid to cap cost of over 800 plus formulations to make them affordable.
-
US Department Of Justice Summons Taro Over Generic Drugs Pricing
US Department of Justice has sent summons to Sun Pharmaceutical Industries' US arm Taro Pharmaceutical Industries Inc and its two senior executives seeking information on generic drug pricing. has sent summons to Sun Pharmaceutical Industries' US arm Taro Pharmaceutical Industries Inc and its two senior executives seeking information on generic dru...
-
Sun Pharma Gets US Summons Over Drug Pricing, Shares Flat
The US Department of Justice (DoJ) on Saturday sought information from Sun Pharma about pricing and marketing of generic drugs that it sells in that country.
-
Sun Pharma Gets US Subpoena Over Generic Drugs Pricing
The US Department of Justice (DoJ) has subpoenaed India's largest drug maker Sun Pharmaceutical Industries Ltd seeking information about the pricing and marketing of the generic drugs it sells in the United States, the company said on Saturday.
-
Global Pharma Growth Seen Steady In 12-18 Months: Moody's
Global pharmaceutical industry will see an annual earnings growth of 3-4 per cent over the next 12-18 months as solid underlying fundamentals mitigate the effect of the strong US dollar and increasing scrutiny of drug prices, said Moody's Investors Service.
-
126 Drugs Cheaper by Over 40% as Government Fixes Ceiling
Government has fixed the ceiling price of 530 essential medicines that has resulted in price reduction of over 40 per cent in case of 126 drugs, Parliament was informed on Friday.
-
New "Vaccine-Like" HIV Drug Could Cost 1,000 Times Less Than Current Price
A new "vaccine-like" HIV drug that currently costs over $40,000 per person a year could be made for as little as $40, researchers estimated on Tuesday.
-
Sweden Forced to Pay Jailed Drug Dealer Over $1.5 Million in Bitcoin: Find Out Why
In a recent ruling, Sweden's government is being forced to pay more than $1.5 Million (roughly Rs. 11 crores) to a drug dealer who was jailed in 2019 after the Bitcoin he had illegally amassed appreciated while he was in custody. Read all about it here.
-
Cadila Healthcare Gains Over 2% After Unit Buys Drug For Menkes Disease
Cadila Healthcare said that its US subsidiary has acquired an experimental drug from Cyprium for treating Menkes disease, which is a rare recessive pediatric disease
-
Gilead Prices COVID-19 Drug Remdesivir At $2,340 Per Patient In Developed Nations
Gilead Sciences Inc on Monday priced its COVID-19 antiviral remdesivir at $2,340 per patient for wealthier nations and agreed to send nearly all of its supply of the drug to the United States over the next three months.
-
Cipla Gets Regulatory Nod To Make Gilead's COVID-19 Drug, Shares Hit Record High
Cipla shares surged over 9% after it got an approval from DCGI to manufacture and market generic COVID-19 drug Remdesivir.
-
Why Shares Of This Bengaluru-Based Drug Maker Plunged Over 8% Today
US FDA had inspected Strides Pharma's drug manufacturing facility in Puducherry from January 28 to February 5, 2019 and said that the company was caught trying to dispose quality-control records.
-
Expected Rise In Drug Prices Post-GST Create Panic
The expected rise in drug prices post-GST has created chaos among the customers who are in dire need of life-surviving drugs. With uncertainty over tax slabs, pharma companies are in complete disorder.
-
US Consumers Will Want Donald Trump, Congress To Take On Drug Prices
Americans' growing alarm over rising prescription drug costs will pressure a new US administration and Congress to take action on pharmaceutical pricing, industry executives and healthcare experts say.
-
Hillary Clinton Win May Pose Pricing Challenges For Pharma Firms: Report
Both US presidential candidates have argued in favour of allowing the US government's Medicare programme, which accounts for over 20 per cent of total US drug spend, to directly negotiate drug prices with manufacturers.
-
Government Cuts Prices Of 10 Drugs, Brings 8 More Under Control
Government has slashed prices of 10 more drugs while bringing eight new medicines, including paracetamol, under price control for the first time in its bid to cap cost of over 800 plus formulations to make them affordable.
-
US Department Of Justice Summons Taro Over Generic Drugs Pricing
US Department of Justice has sent summons to Sun Pharmaceutical Industries' US arm Taro Pharmaceutical Industries Inc and its two senior executives seeking information on generic drug pricing. has sent summons to Sun Pharmaceutical Industries' US arm Taro Pharmaceutical Industries Inc and its two senior executives seeking information on generic dru...
-
Sun Pharma Gets US Summons Over Drug Pricing, Shares Flat
The US Department of Justice (DoJ) on Saturday sought information from Sun Pharma about pricing and marketing of generic drugs that it sells in that country.
-
Sun Pharma Gets US Subpoena Over Generic Drugs Pricing
The US Department of Justice (DoJ) has subpoenaed India's largest drug maker Sun Pharmaceutical Industries Ltd seeking information about the pricing and marketing of the generic drugs it sells in the United States, the company said on Saturday.
-
Global Pharma Growth Seen Steady In 12-18 Months: Moody's
Global pharmaceutical industry will see an annual earnings growth of 3-4 per cent over the next 12-18 months as solid underlying fundamentals mitigate the effect of the strong US dollar and increasing scrutiny of drug prices, said Moody's Investors Service.
-
126 Drugs Cheaper by Over 40% as Government Fixes Ceiling
Government has fixed the ceiling price of 530 essential medicines that has resulted in price reduction of over 40 per cent in case of 126 drugs, Parliament was informed on Friday.
